AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 57 filers reported holding AKCEA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $795,000 | +44.5% | 43,813 | +9.2% | 0.42% | +60.4% |
| Q2 2020 | $550,000 | +26.1% | 40,123 | +31.6% | 0.26% | +45.3% |
| Q1 2020 | $436,000 | -22.1% | 30,486 | -7.8% | 0.18% | +94.6% |
| Q4 2019 | $560,000 | +227.5% | 33,059 | +197.5% | 0.09% | +170.6% |
| Q3 2019 | $171,000 | -37.8% | 11,111 | -5.3% | 0.03% | -41.4% |
| Q2 2019 | $275,000 | +13.6% | 11,730 | +37.6% | 0.06% | -88.7% |
| Q1 2019 | $242,000 | -16.6% | 8,527 | -11.3% | 0.52% | +930.0% |
| Q4 2018 | $290,000 | -57.4% | 9,610 | -50.5% | 0.05% | -28.6% |
| Q3 2018 | $680,000 | -13.9% | 19,429 | -41.7% | 0.07% | -90.0% |
| Q2 2018 | $790,000 | -21.6% | 33,315 | -15.3% | 0.70% | -20.2% |
| Q1 2018 | $1,008,000 | +221.0% | 39,351 | +117.8% | 0.88% | +122.1% |
| Q4 2017 | $314,000 | – | 18,071 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |